Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication

PHASE4CompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

November 30, 2010

Conditions
Helicobacter Infection
Interventions
DRUG

pantoprazole

pantoprazole 40mg bid

DRUG

bismuth

bismuth 300mg qid

DRUG

metronidazole

metronidazole 500mg tid

DRUG

tetracycline

tetracycline 500mg qid

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Inje University

OTHER

collaborator

Pacific Pharmaceuticals

INDUSTRY

lead

Asan Medical Center

OTHER